MNKD - MANNKIND CORP
IEX Last Trade
6.76
-0.030 -0.444%
Share volume: 19,909
Last Updated: Fri 27 Dec 2024 04:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.12%
PREVIOUS CLOSE
CHG
CHG%
$6.79
-0.03
-0.44%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-02-23 | 2023-05-09 | 2023-08-07 | 2023-11-07 | 2024-02-27 | 2024-05-08 | |
| Total revenue | 18.894 M | 32.825 M | 36.059 M | 40.626 M | 48.611 M | 51.253 M | 58.472 M | 66.263 M | |
| Cost of revenue | 12.915 M | 17.460 M | 16.124 M | 16.213 M | 14.237 M | 14.254 M | 18.067 M | 18.598 M | |
| Gross profit | 5.979 M | 15.365 M | 19.935 M | 24.413 M | 34.374 M | 36.999 M | 40.405 M | 47.665 M | |
| 156.98% | 29.74% | 22.46% | 40.80% | 7.64% | 9.21% | 17.97% | |||
| Operating expenses | 30.936 M | 26.774 M | 29.251 M | 29.457 M | 32.402 M | 33.967 M | 29.771 M | 32.342 M | |
| Selling general and admin | 26.043 M | 22.638 M | 22.095 M | 23.852 M | 25.949 M | 23.978 M | 20.535 M | 22.329 M | |
| Research and development | 4.893 M | 4.136 M | 7.156 M | 5.605 M | 6.453 M | 9.989 M | 9.236 M | 10.013 M | |
| Total expenses | 43.851 M | 44.234 M | 45.375 M | 45.670 M | 46.639 M | 48.221 M | 47.838 M | 50.940 M | |
| 0.87% | 2.58% | 0.65% | 2.12% | 3.39% | -0.79% | 6.48% | |||
| Operating income | -24.957 M | -11.409 M | -9.316 M | -5.044 M | 1.972 M | 3.032 M | 10.634 M | 15.323 M | |
| Ebit | -24.957 M | -11.409 M | -9.316 M | -5.044 M | 1.972 M | 3.032 M | 10.634 M | 15.323 M | |
| Pretax income | -29.023 M | -14.432 M | -17.947 M | -9.795 M | -5.265 M | 1.721 M | 2.962 M | 10.894 M | |
| -50.27% | 24.36% | -45.42% | -46.25% | -132.69% | 72.11% | 267.79% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.561 M | 264.000 K | |
| Net income basic | -29.023 M | -14.432 M | -17.947 M | -9.795 M | -5.265 M | 1.721 M | 1.401 M | 10.630 M | |
| 50.27% | -24.36% | 45.42% | 46.25% | 132.69% | -18.59% | 658.74% | |||
| Net income | -29.023 M | -14.432 M | -17.947 M | -9.795 M | -5.265 M | 1.721 M | 1.401 M | 10.630 M | |
| 50.27% | -24.36% | 45.42% | 46.25% | 132.69% | -18.59% | 658.74% |